Aerosolised liposomal hamycin for treatment of systemic Candida infections in mice

FEMS Immunology and Medical Microbiology

Volumn 25, Issue 3, 1999, Pages 231-236

  Dhuley, Jayant N ^a  

^a Res Div Hindustan Antibiot L   (India)

Author keywords

Aerosolized liposomal hamycin; Candida infection

Indexed keywords

HAMYCIN; LIPOSOME;

AEROSOL; ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; DRUG TISSUE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INHALATIONAL DRUG ADMINISTRATION; KIDNEY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SURVIVAL RATE; SURVIVAL TIME;

AEROSOLS; ANIMALS; CANDIDIASIS; DRUG ADMINISTRATION SCHEDULE; DRUG CARRIERS; LIPOSOMES; MALE; MICE; MICE, INBRED BALB C; POLYENES; TISSUE DISTRIBUTION;

EID: 0032808226     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(99)00092-9     Document Type: Article

References (18)

1. Anaissie E. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin. Infect. Dis. 14:1992;S43-S53.
2. Korting H.C., Ollert M., Georgii A., Froschl M. In vitro susceptibilities and biotypes of Candida albicans isolates from the oral of patients infected with human immunodeficiency virus. J. Clin. Microbiol. 26:1988;2626-2631.
3. Lopez-Berestein G., Fainstein V., Hopfer R., Mehta K., Sullivan M.P., Keating M., Rosenblum M.G., Mehta R., Luna M., Hersh E.M., Reuben J., Juliano R.L., Bodey G.P. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J. Infect. Dis. 151:1985;704-710.
4. Thirumalachar, M.J. and Narsimhan, M.J. (1987) Hamycin: twenty years and the future. In: Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents (Fromtling, R.A., Ed.), pp. 619-632. J.R. Prous Science, Barcelona.
5. Mehta R.T., McQueen T.J., Keyhani A., Lopez-Berestein G. Liposomal hamycin: Reduced toxicity and improved antifungal efficacy in vitro and in vivo. J. Infect. Dis. 164:1991;1003-1006.
6. Dhuley J.N. Antifungal antibiotic hamycin increases susceptibility of Candida albicans to phagocytosis by murine macrophages. FEMS Immunol. Med. Microbiol. 20:1998;153-157.
7. Kretschmar M., Nichterlein T., Hannak D., Hof H. Effects of amphotericin B incorporated into liposomes and in lipid suspensions in the treatment of murine candidiasis. Arzneim. Forsch. 46:1996;711-715.
8. Viviani M.A., Rizzardini G., Tortorano A.M., Fasan M., Capetti A., Roverselli A.M., Gringeri A., Suter F. Lipid-based amphotericin B in the treatment of cryptococcosis. Infection. 22:1994;137-142.
9. Moonis M., Ahmad I., Bachhawat B.K. Mannosylated liposomes as carriers for hamycin in the treatment of experimental aspergillosis in Balb/c mice. J. Drug Target. 1:1993;147-155.
10. Pandey R.C., Rinehart K.L. An improved method for the preparation of methylesters of polyene antibiotics. J. Antibiot. 30:1977;158-162.
11. Garcon N.M., Six H.R., Frazer J., Hazelwood C., Gilbert B.E., Knight V. Liposomes of enviroxime and phosphatidylcholine: definition of the drug-phospholipid interactions. Antiviral Res. 11:1989;89-98.
12. Gilbert B.E., Wyde P.R., Wilson S.Z. Aerosolized liposmal amphotericin B for treatment of pulmonary and systemic Cryptococcus neoformans infections in mice. Antimicrob. Agents Chemother. 36:1992;1466-1471.
13. Gilbert B.E., Knight V. Biochemistry and clinical applications of ribavirin. Antimicrob. Agents Chemother. 30:1996;201-205.
14. Lopez-Berestein, G. and Juliatno, R.L. (1987) Application of liposomes to the delivery of antifungal agents. In: Liposomes: From Biophysics to Therapeutics (Ostro, M.J., Ed.), pp. 253-276. Marcel Dekker, New York.
15. Moonis M., Ahmad I., Bachhawat B.K. Liposomal hamycin in the control of experimental aspergillosis in mice: Relative toxicity, therapeutic efficacy and tissue distribution of free and liposomal hamycin. Indian J. Biochem. Biophys. 29:1992;339-345.
16. Schmitt H.J., Bernard E.M., Hauser M., Armstrong D. Aerosol amphotericin B is effective for prophylaxis and therapy in a rat model of pulmonary aspergillosis. Antimicrob. Agents Chemother. 32:1988;1676-1679.
17. Niki Y., Bernard E.M., Schmitt H.J., Tong W.P., Edwards F.F., Armstrong D. Pharmacokinetics of aerosol amphotericin B in rats. Antimicrob. Agents Chemother. 34:1990;29-32.
18. Diamond R.D. The growing problem of mycoses in patients infected with the human immunodeficiency virus. Rev. Infect. Dis. 13:1991;480-486.